Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 248

The DOI matches its Crossref record.

Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial

Open access
Straver, Marieke E., Meijnen, Philip, van Tienhoven, Geertjan, van de Velde, Cornelis J. H., Mansel, Robert E., Bogaerts, Jan, Duez, Nicole, Cataliotti, Luigi, Klinkenbijl, Jean H. G., Westenberg, Helen A., van der Mijle, Huub, Snoj, Marko, Hurkmans, Coen, Rutgers, Emiel J. T. · 2010 · Annals of Surgical Oncology

Abstract

BACKGROUND: The randomized EORTC 10981-22023 AMAROS trial investigates whether breast cancer patients with a tumor-positive sentinel node biopsy (SNB) are best treated with an axillary lymph node dissection (ALND) or axillary radiotherapy (ART). The aim of the current substudy was to evaluate the identification rate and the nodal involvement. METHODS: The first 2,000 patients participating in the AMAROS trial were evaluated. Associations between the identification rate and technical, patient-, and tumor-related factors were evaluated. The outcome of the SNB procedure and potential further nodal involvement was assessed. RESULTS: In 65 patients, the sentinel node could not be identified. As a result, the sentinel node identification rate was 97% (1,888 of 1,953). Variables affecting the success rate were age, pathological tumor size, histology, year of accrual, and method of detection. The SNB results of 65% of the patients (n = 1,220) were negative and the patients underwent no further axillary treatment. The SNB results were positive in 34% of the patients (n = 647), including macrometastases (n = 409, 63%), micrometastases (n = 161, 25%), and isolated tumor cells (n = 77, 12%). Further nodal involvement in patients with macrometastases, micrometastases, and isolated tumor cells undergoing an ALND was 41, 18, and 18%, respectively. CONCLUSIONS: With a 97% detection rate in this prospective international multicenter study, the SNB procedure is highly effective, especially when the combined method is used. Further nodal involvement in patients with micrometastases and isolated tumor cells in the sentinel node was similar-both were 18%.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1245/s10434-010-0945-z

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 248

Metadata

Authors
Straver, M. E., Meijnen, P., van Tienhoven, G., van de Velde, C. J. H., Mansel, R. E., Bogaerts, J., Duez, N., Cataliotti, L., Klinkenbijl, J. H. G., Westenberg, H. A., van der Mijle, H., Snoj, M., Hurkmans, C., & Rutgers, E. J. T.
Venue
Annals of Surgical Oncology
Published
2010-03-19
Volume
17
Issue
7
Pages
1854-1861
ISSN
  • 1068-9265 (ISSN-L)
  • 1534-4681
OpenAlex
W2169883647
Cited by
248
References
0
FWCI
7.59
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial. https://app.cochat.ai/papers/10.1245/s10434-010-0945-z
The paper
Straver, M. E., Meijnen, P., van Tienhoven, G., van de Velde, C. J. H., Mansel, R. E., Bogaerts, J., Duez, N., Cataliotti, L., Klinkenbijl, J. H. G., Westenberg, H. A., van der Mijle, H., Snoj, M., Hurkmans, C., & Rutgers, E. J. T. (2010). Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-010-0945-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.